Publications for Sten Wingren
Co-author map based on ISI articles 2007-

Keywords

young women tumours tamoxifen survival risk protein prognostic postmenopausal polymorphism patients p53 onset oestrogen loh gene em> cancer breast allele

Journal Articles

Pia Palmebäck Wegman, Nashwan J Marcus, Breezy Paul Malakkaran and Sten Wingren
  Biological significance of allele specific loss of the p53 gene in breast carcinomas
  BREAST CANCER RESEARCH AND TREATMENT, 2009, 118(1), 15-20.
 Web of Science® Times Cited: 4

Anna Lang, Pia Palmeback Wegman and Sten Wingren
  The significance of MDM2 SNP309 and p53 Arg72Pro in young women with breast cancer
  ONCOLOGY REPORTS, 2009, 22(3), 575-579.
 Web of Science® Times Cited: 13

Barbara E. Licznerska, Pia P. Wegman, Bo Nordenskjöld and Sten Wingren
  In situ levels of oestrogen producing enzymes and its prognostic significance in postmenopausal breast cancer patients
  Breast Cancer Research and Treatment, 2008, 112(1), 15-23.
 Web of Science® Times Cited: 7

Piiha-Lotta Jerevall, Sara Brommesson, Carina Strand, Sofia Gruvberger-Saal, Per Malmström, Bo Nordenskjöld, Sten Wingren, Peter Söderkvist, Mårten Fernö and Olle Stål
  Exploring the two-gene ratio in breast cancer – independent roles for HOXB13 and IL17BR in prediction of clinical outcome
  Breast Cancer Research and Treatment, 2008, 107(2), 225-234.
   Fulltext  PDF  
 Web of Science® Times Cited: 25

Pia Wegman Palmebäck, Sauli Elingarami, John Carstensen, Olle Stål, Bo Nordenskjöld and Sten Wingren
  Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal breast cancer patients
  Breast Cancer Research, 2007, 9(1), R7.
   Fulltext  PDF  
 Web of Science® Times Cited: 147

Pia Wegman (Palmebäck), Olle Stål, Marie Stenmark Askmalm, Bo Nordenskjöld, Lars-Erik Rutqvist and Sten Wingren
  p53 polymorphic variants at codon 72 and the outcome of therapy in randomized breast cancer patients
  Pharmacogenetics and Genomics, 2006, 16(5), 347-351.
 Web of Science® Times Cited: 14

Pia Palmebäck Wegman and Sten Wingren
  CYP2D6 variants and the prediction of tamoxifen response in randomized patients: authors' response
  Breast Cancer Research, 2005, 7(6), 234-234.

Piiha-Lotta Jerevall, Ahmad Ahmadi, Malin Bergman, Olle Stål and Sten Wingren
  Sulfotransferase1A1 and risk of postmenopausal breast cancer
  Anticancer Research, 2005, 25(3 C), 2515-2517.
 Web of Science® Times Cited: 10

Malin Bergman, Marie Ahnström, Pia Palmebäck Wegman and Sten Wingren
  Polymorphism in the manganese superoxide dismutase (MnSOD) gene and risk of breast cancer in young women
  Journal of Cancer Research and Clinical Oncology, 2005, 131(7), 439-444.
 Web of Science® Times Cited: 26

Pia Wegman (Palmebäck), Linda Vainikka, Olle Stål, Bo Nordenskjöld, Lambert Skoog, Lars-Erik Rutqvist and Sten Wingren
  Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients
  Breast Cancer Research, 2005, 7(3), R284-R290.
   Fulltext  PDF  
 Web of Science® Times Cited: 122

Marie Sundquist, Sten Thorstenson, Lars Brudin, Sten Wingren and Bo Nordenskjöld
  Incidence and prognosis in early onset breast cancer
  Breast, 2002, 11(1), 30-35.
 Web of Science® Times Cited: 19

Massimiliano Gentile, Åsa Wiman, Sten Thorstenson, Niklas Loman, Åke Borg and Sten Wingren
  Deletion mapping of chromosome segment 11q24-q25, exhibiting extensive allelic loss in early onset breast cancer
  International Journal of Cancer, 2001, 92(2), 208-213.
 Web of Science® Times Cited: 19

Malin Bergman-Jungeström and Sten Wingren
  Catechol-O-Methyltransferase (COMT) gene polymorphism and breast cancer risk in young women
  British Journal of Cancer, 2001, 85(6), 859-862.
 Web of Science® Times Cited: 36

Askmalm Marie Stenmark-Askmalm, Massimiliano Gentile, Sten Wingren, Olle Stål and Lars-Gunnar Arnesson
  Protein accumulation and gene mutation of p53 in bilateral breast cancer
  Acta Oncologica, 2001, 40(1), 56-62.
 Web of Science® Times Cited: 8

Massimiliano Gentile, Marie Ahnström, Fredrik Schön and Sten Wingren
  Candidate tumour suppressor genes at 11q23-q24 in breast cancer: evidence of alterations in PIG8, a gene involved in p53-induced apoptosis
  Oncogene, 2001, 20(53), 7753-7760.
 Web of Science® Times Cited: 36

Måns Agrup, Olle Stål, Karen Olsen and Sten Wingren
  C-erbB-2 overexpression and survival in early onset breast cancer
  Breast Cancer Research and Treatment, 2000, 63(1), 23-29.
 Web of Science® Times Cited: 36

Massimiliano Gentile, K. Olsen, Monika Dufmats and Sten Wingren
  Frequent allelic losses at 11q24.1–q25 in young women with breast cancer: association with poor survival
  British Journal of Cancer, 1999, 80(5/6), 843-849.

Anna-Carin Lundin, Peter Söderkvist, Birgitta Eriksson, Malin Bergman-Jungeström and Sten Wingren
  Association of breast cancer progression with a vitamin D receptor gene polymorphism
  Cancer Research, 1999, 59(10), 2332-2334.

Malin Bergman-Jungeström, Massiliano Gentile, Anna-Carin Lundin and Sten Wingren
  Association between CYP17 gene polymorphism and risk of breast cancer in young women
  International Journal of Cancer, 1999, 84, 350-353.

Massimiliano Gentile, Malin Bergman Jungeström, K. E. Olsen, Peter Söderkvist and Sten Wingren
  p53 and survival in early onset breast cancer: analysis of gene mutations, loss of heterozygosity and protein accumulation
  European Journal of Cancer, 1999, 35(8), 1202-1207.

Avni Abdiu, Sten Wingren, S-E Larsson, Åke Wasteson and Thomas Walz
  Effects of human platelet-derived growth factor-AB on sarcoma growth in vitro and in vivo.
  Cancer Letters, 1999, 141, 39-45.

Ph.D. Theses

Pia Palmebäck Wegman
  Studies of tamoxifen resistance in breast cancer
  2007.


  Fulltext PDF

Sten Wingren
  DNA flow cytometry of cytokeratin selected breast cancer cells as prognostic indicator
  1994.